Business Practice

Mike Rea of IDEA Pharma shares his thoughts on what players in pharma positioning are getting right – and wrong.

How a drug approval changed the lives of patients living with rare disease.

Defining the best strategies for working with highly potent drug substances.

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

What strategies can pharma employ to protect itself against cyber threats?

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.